Increasing Insulin Resistance as a Predictor of Impending Bacteremia

Increasing Insulin Resistance as a Predictor of Impending Bacteremia: A Retrospective Study

NCT04992689•Meir Medical Center

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Acquired ICU Bacteremia

Locations

Israel

Locations (1)

Meir medical center Kfar Saba

Kfar Saba, Israel

Key Dates

Start Date

December 1, 2021

Primary Completion Date

January 1, 2024

Completion Date

January 1, 2024

Last Updated

March 15, 2024

Sponsors

Lead Sponsor

Meir Medical Center

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 15, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions